Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden

• Kari Hemminki ,

  Roles Conceptualization, Formal analysis, Project administration

  * E-mail: K.Hemminki@dkfz.de

  Affiliations Biomedical Center, Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen, Czech Republic, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

  https://orcid.org/0000-0002-2769-3316

  ⨯
• Asta Försti,

  Roles Investigation, Validation

  Affiliations Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany, Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany

  ⨯
• Akseli Hemminki,

  Roles Investigation, Validation

  Affiliations Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland

  ⨯
• Börje Ljungberg,

  Roles Investigation, Validation

  Affiliation Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden

  https://orcid.org/0000-0002-4121-3753

  ⨯
• Otto Hemminki

  Roles Conceptualization, Formal analysis, Supervision

  Affiliations Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland, Department of Urology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland, Division of Urologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Center, University Health Network and University of Toronto, Toronto, Ontario, Canada

  ⨯